PittsburghV1, PubMed, Curation, bibRecord, 000E22

Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial.

Identifieur interne : 000E22 ( PubMed/Curation ); précédent : 000E21; suivant : 000E23

Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial.

Auteurs : Laurie W. Cuttino [États-Unis] ; Douglas W. Arthur [États-Unis] ; Frank Vicini [États-Unis] ; Dorin Todor [États-Unis] ; Thomas Julian [États-Unis] ; Nitai Mukhopadhyay [États-Unis]

Source :

International journal of radiation oncology, biology, physics [ 1879-355X ] ; 2014.

RBID : pubmed:25442036

Descripteurs français

English descriptors

KwdEn :
- Brachytherapy (instrumentation), Brachytherapy (methods), Breast Neoplasms (epidemiology), Breast Neoplasms (radiotherapy), Cancer Care Facilities, Carcinoma, Ductal, Breast (epidemiology), Carcinoma, Ductal, Breast (radiotherapy), Carcinoma, Lobular (epidemiology), Carcinoma, Lobular (radiotherapy), Catheters, Disease-Free Survival, Dose Fractionation, Female, Follow-Up Studies, Hospitals, High-Volume, Humans, Incidence, Neoplasm Recurrence, Local (epidemiology), Neoplasms, Second Primary (epidemiology), Seroma (epidemiology), Treatment Outcome.
MESH :
- epidemiology : Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular, Neoplasm Recurrence, Local, Neoplasms, Second Primary, Seroma.
- instrumentation : Brachytherapy.
- methods : Brachytherapy.
- radiotherapy : Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular.
- Cancer Care Facilities, Catheters, Disease-Free Survival, Dose Fractionation, Female, Follow-Up Studies, Hospitals, High-Volume, Humans, Incidence, Treatment Outcome.

Abstract

To describe the long-term outcomes from a completed, multi-institutional phase 4 registry trial using the Contura multilumen balloon (CMLB) breast brachytherapy catheter to deliver accelerated partial breast irradiation (APBI) in patients with early-stage breast cancer.

DOI: 10.1016/j.ijrobp.2014.08.341
PubMed: 25442036

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000E25

Links to Exploration step

pubmed:25442036

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial.</title>
<author><name sortKey="Cuttino, Laurie W" sort="Cuttino, Laurie W" uniqKey="Cuttino L" first="Laurie W" last="Cuttino">Laurie W. Cuttino</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia. Electronic address: lcuttino@mcvh-vcu.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Virginie</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Virginia Commonwealth University, Richmond</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Arthur, Douglas W" sort="Arthur, Douglas W" uniqKey="Arthur D" first="Douglas W" last="Arthur">Douglas W. Arthur</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Virginie</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Virginia Commonwealth University, Richmond</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Vicini, Frank" sort="Vicini, Frank" uniqKey="Vicini F" first="Frank" last="Vicini">Frank Vicini</name>
<affiliation wicri:level="2"><nlm:affiliation>Michigan Healthcare Professionals/21st Century Onoclogy, Farmington Hills, Michigan.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Michigan</region>
</placeName>
<wicri:cityArea>Michigan Healthcare Professionals/21st Century Onoclogy, Farmington Hills</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Todor, Dorin" sort="Todor, Dorin" uniqKey="Todor D" first="Dorin" last="Todor">Dorin Todor</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Virginie</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Virginia Commonwealth University, Richmond</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Julian, Thomas" sort="Julian, Thomas" uniqKey="Julian T" first="Thomas" last="Julian">Thomas Julian</name>
<affiliation wicri:level="2"><nlm:affiliation>Allegheny Hospital, Temple School of Medicine, Pittsburgh, Pennsylvania.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Allegheny Hospital, Temple School of Medicine, Pittsburgh</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mukhopadhyay, Nitai" sort="Mukhopadhyay, Nitai" uniqKey="Mukhopadhyay N" first="Nitai" last="Mukhopadhyay">Nitai Mukhopadhyay</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Virginie</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Virginia Commonwealth University, Richmond</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25442036</idno>
<idno type="pmid">25442036</idno>
<idno type="doi">10.1016/j.ijrobp.2014.08.341</idno>
<idno type="wicri:Area/PubMed/Corpus">000E25</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000E25</idno>
<idno type="wicri:Area/PubMed/Curation">000E22</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000E22</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial.</title>
<author><name sortKey="Cuttino, Laurie W" sort="Cuttino, Laurie W" uniqKey="Cuttino L" first="Laurie W" last="Cuttino">Laurie W. Cuttino</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia. Electronic address: lcuttino@mcvh-vcu.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Virginie</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Virginia Commonwealth University, Richmond</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Arthur, Douglas W" sort="Arthur, Douglas W" uniqKey="Arthur D" first="Douglas W" last="Arthur">Douglas W. Arthur</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Virginie</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Virginia Commonwealth University, Richmond</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Vicini, Frank" sort="Vicini, Frank" uniqKey="Vicini F" first="Frank" last="Vicini">Frank Vicini</name>
<affiliation wicri:level="2"><nlm:affiliation>Michigan Healthcare Professionals/21st Century Onoclogy, Farmington Hills, Michigan.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Michigan</region>
</placeName>
<wicri:cityArea>Michigan Healthcare Professionals/21st Century Onoclogy, Farmington Hills</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Todor, Dorin" sort="Todor, Dorin" uniqKey="Todor D" first="Dorin" last="Todor">Dorin Todor</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Virginie</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Virginia Commonwealth University, Richmond</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Julian, Thomas" sort="Julian, Thomas" uniqKey="Julian T" first="Thomas" last="Julian">Thomas Julian</name>
<affiliation wicri:level="2"><nlm:affiliation>Allegheny Hospital, Temple School of Medicine, Pittsburgh, Pennsylvania.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Allegheny Hospital, Temple School of Medicine, Pittsburgh</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mukhopadhyay, Nitai" sort="Mukhopadhyay, Nitai" uniqKey="Mukhopadhyay N" first="Nitai" last="Mukhopadhyay">Nitai Mukhopadhyay</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Virginie</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Virginia Commonwealth University, Richmond</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">International journal of radiation oncology, biology, physics</title>
<idno type="eISSN">1879-355X</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Brachytherapy (instrumentation)</term>
<term>Brachytherapy (methods)</term>
<term>Breast Neoplasms (epidemiology)</term>
<term>Breast Neoplasms (radiotherapy)</term>
<term>Cancer Care Facilities</term>
<term>Carcinoma, Ductal, Breast (epidemiology)</term>
<term>Carcinoma, Ductal, Breast (radiotherapy)</term>
<term>Carcinoma, Lobular (epidemiology)</term>
<term>Carcinoma, Lobular (radiotherapy)</term>
<term>Catheters</term>
<term>Disease-Free Survival</term>
<term>Dose Fractionation</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Hospitals, High-Volume</term>
<term>Humans</term>
<term>Incidence</term>
<term>Neoplasm Recurrence, Local (epidemiology)</term>
<term>Neoplasms, Second Primary (epidemiology)</term>
<term>Seroma (epidemiology)</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Carcinome canalaire du sein (radiothérapie)</term>
<term>Carcinome canalaire du sein (épidémiologie)</term>
<term>Carcinome lobulaire (radiothérapie)</term>
<term>Carcinome lobulaire (épidémiologie)</term>
<term>Cathéters</term>
<term>Curiethérapie ()</term>
<term>Curiethérapie (instrumentation)</term>
<term>Femelle</term>
<term>Fractionnement de la dose d'irradiation</term>
<term>Humains</term>
<term>Hôpitaux à haut volume d'activité</term>
<term>Incidence</term>
<term>Récidive tumorale locale (épidémiologie)</term>
<term>Résultat thérapeutique</term>
<term>Seconde tumeur primitive (épidémiologie)</term>
<term>Survie sans rechute</term>
<term>Sérome (épidémiologie)</term>
<term>Tumeurs du sein (radiothérapie)</term>
<term>Tumeurs du sein (épidémiologie)</term>
<term>Établissements de cancérologie</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Breast Neoplasms</term>
<term>Carcinoma, Ductal, Breast</term>
<term>Carcinoma, Lobular</term>
<term>Neoplasm Recurrence, Local</term>
<term>Neoplasms, Second Primary</term>
<term>Seroma</term>
</keywords>
<keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Brachytherapy</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Brachytherapy</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term>
<term>Carcinoma, Ductal, Breast</term>
<term>Carcinoma, Lobular</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Carcinome canalaire du sein</term>
<term>Carcinome lobulaire</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Carcinome canalaire du sein</term>
<term>Carcinome lobulaire</term>
<term>Curiethérapie</term>
<term>Récidive tumorale locale</term>
<term>Seconde tumeur primitive</term>
<term>Sérome</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Cancer Care Facilities</term>
<term>Catheters</term>
<term>Disease-Free Survival</term>
<term>Dose Fractionation</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Hospitals, High-Volume</term>
<term>Humans</term>
<term>Incidence</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Cathéters</term>
<term>Curiethérapie</term>
<term>Femelle</term>
<term>Fractionnement de la dose d'irradiation</term>
<term>Humains</term>
<term>Hôpitaux à haut volume d'activité</term>
<term>Incidence</term>
<term>Résultat thérapeutique</term>
<term>Survie sans rechute</term>
<term>Établissements de cancérologie</term>
<term>Études de suivi</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To describe the long-term outcomes from a completed, multi-institutional phase 4 registry trial using the Contura multilumen balloon (CMLB) breast brachytherapy catheter to deliver accelerated partial breast irradiation (APBI) in patients with early-stage breast cancer.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25442036</PMID>
<DateCreated><Year>2014</Year>
<Month>12</Month>
<Day>25</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>02</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>12</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-355X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>90</Volume>
<Issue>5</Issue>
<PubDate><Year>2014</Year>
<Month>Dec</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>International journal of radiation oncology, biology, physics</Title>
<ISOAbbreviation>Int. J. Radiat. Oncol. Biol. Phys.</ISOAbbreviation>
</Journal>
<ArticleTitle>Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial.</ArticleTitle>
<Pagination><MedlinePgn>1025-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijrobp.2014.08.341</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0360-3016(14)04048-6</ELocationID>
<Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To describe the long-term outcomes from a completed, multi-institutional phase 4 registry trial using the Contura multilumen balloon (CMLB) breast brachytherapy catheter to deliver accelerated partial breast irradiation (APBI) in patients with early-stage breast cancer.</AbstractText>
<AbstractText Label="METHODS AND MATERIALS" NlmCategory="METHODS">Three hundred forty-two evaluable patients were enrolled by 23 institutions between January 2008 and February 2011. All patients received 34 Gy in 10 fractions, delivered twice daily. Rigorous target coverage and normal tissue dose constraints were observed.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The median follow-up time was 36 months (range, 1-54 months). For the entire patient cohort of 342 patients, 10 patients experienced an ipsilateral breast tumor recurrence (IBTR). Eight of these IBTR were classified as true recurrences/marginal miss (TRMM), and 2 were elsewhere failures (EF). Local recurrence-free survival was 97.8% at 3 years. For the entire cohort, 88% of patients had good to excellent overall cosmesis. The overall incidence of infection was 8.5%. Symptomatic seroma was reported in only 4.4% of patients. A separate analysis was performed to determine whether improved outcomes would be observed for patients treated at high-volume centers with extensive brachytherapy experience. Three IBTR were observed in this cohort, only 1 of which was classified as a TRMM. Local recurrence-free survival at high-volume centers was 98.1% at 3 years. Overall cosmetic outcome and toxicity were superior in patients treated at high-volume centers. In these patients, 95% had good to excellent overall cosmesis. Infection was observed in only 2.9% of patients, and symptomatic seroma was reported in only 1.9%.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Use of the CMLB for APBI delivery is associated with acceptable long-term local control and toxicity. Local recurrence-free survival was 97.8% at 3 years. Significant (grade 3) toxicity was uncommon, and no grade 4 toxicity was observed. Treatment at high-volume centers was associated with decreased late toxicity.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cuttino</LastName>
<ForeName>Laurie W</ForeName>
<Initials>LW</Initials>
<AffiliationInfo><Affiliation>Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia. Electronic address: lcuttino@mcvh-vcu.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Arthur</LastName>
<ForeName>Douglas W</ForeName>
<Initials>DW</Initials>
<AffiliationInfo><Affiliation>Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vicini</LastName>
<ForeName>Frank</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Michigan Healthcare Professionals/21st Century Onoclogy, Farmington Hills, Michigan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Todor</LastName>
<ForeName>Dorin</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Julian</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Allegheny Hospital, Temple School of Medicine, Pittsburgh, Pennsylvania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mukhopadhyay</LastName>
<ForeName>Nitai</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList><AccessionNumber>NCT00699101</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList><PublicationType UI="D017429">Clinical Trial, Phase IV</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>10</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Int J Radiat Oncol Biol Phys</MedlineTA>
<NlmUniqueID>7603616</NlmUniqueID>
<ISSNLinking>0360-3016</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001918" MajorTopicYN="N">Brachytherapy</DescriptorName>
<QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002173" MajorTopicYN="N">Cancer Care Facilities</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018270" MajorTopicYN="N">Carcinoma, Ductal, Breast</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018275" MajorTopicYN="N">Carcinoma, Lobular</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057785" MajorTopicYN="N">Catheters</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019583" MajorTopicYN="N">Dose Fractionation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D061847" MajorTopicYN="N">Hospitals, High-Volume</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009364" MajorTopicYN="Y">Neoplasm Recurrence, Local</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016609" MajorTopicYN="N">Neoplasms, Second Primary</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D049291" MajorTopicYN="N">Seroma</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>06</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2014</Year>
<Month>08</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>08</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>2</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25442036</ArticleId>
<ArticleId IdType="pii">S0360-3016(14)04048-6</ArticleId>
<ArticleId IdType="doi">10.1016/j.ijrobp.2014.08.341</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E22 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000E22 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Amérique
   |area=    PittsburghV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:25442036
   |texte=   Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:25442036" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a PittsburghV1

This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021

	Serveur d'exploration sur Pittsburgh
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur Pittsburgh

Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial.

Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki